Exact Mass: 450.2076

Exact Mass Matches: 450.2076

Found 11 metabolites which its exact mass value is equals to given mass value 450.2076, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Cediranib

4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline

C25H27FN4O3 (450.2067)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents

   

Rivenprost

Methyl 4-{[2-(3-hydroxy-2-{3-hydroxy-4-[3-(methoxymethyl)phenyl]but-1-en-1-yl}-5-oxocyclopentyl)ethyl]sulphanyl}butanoic acid

C24H34O6S (450.2076)


   

Rivenprost

Rivenprost

C24H34O6S (450.2076)


C78568 - Prostaglandin Analogue

   

ST 24:4;O3;S

3,12-diketo-4,6-petromyzonene-24-sulfate

C24H34O6S (450.2076)


   

N-Benzylquininium chloride

N-Benzylquininium chloride

C27H31ClN2O2 (450.2074)


   

n-benzylquinidinium chloride

n-benzylquinidinium chloride

C27H31ClN2O2 (450.2074)


   
   

Cediranib

Cediranib

C25H27FN4O3 (450.2067)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EK - Vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents

   

methyl 4-[2-[3-hydroxy-2-[(E)-3-hydroxy-4-[3-(methoxymethyl)phenyl]but-1-enyl]-5-oxocyclopentyl]ethylsulfanyl]butanoate

methyl 4-[2-[3-hydroxy-2-[(E)-3-hydroxy-4-[3-(methoxymethyl)phenyl]but-1-enyl]-5-oxocyclopentyl]ethylsulfanyl]butanoate

C24H34O6S (450.2076)


   

Asimadoline (hydrochloride)

Asimadoline (hydrochloride)

C27H31ClN2O2 (450.2074)


Asimadoline (EMD-61753) hydrochloride is an orally active, selective and peripherally active κ-opioid agonist with IC50s of 5.6 nM (guinea pig) and 1.2 nM (human recombinant). Asimadoline hydrochloride has low permeability across the blood brain barrier and has peripheral anti-inflammatory actions. Asimadoline hydrochloride ameliorates allodynia in diabetic rats and has the potential for irritable bowel syndrome (IBS)[1][2][3].

   

NNC 05-2090 (hydrochloride)

NNC 05-2090 (hydrochloride)

C27H31ClN2O2 (450.2074)


NNC 05-2090 hydrochloride is a GABA uptake inhibitor and inhibitor of the β-GABA transporter (BGT-1) (IC50< /sub>: 10.6 μM). NNC 05-2090 hydrochloride also inhibits mGAT2 with a Ki value of 1.4 μM. NNC 05-2090 has anticonvulsant activity and can be used in the study of epilepsy and neurological diseases[1][2][3].